XOMA Corp (NASDAQ:XOMA)
| 33.39 Delayed Data As of Jul 23 |  +0.88 / +2.71%Today’s Change | 15.48 Today|||52-Week Range 46.32 | -24.34% Year-to-Date |
Latest XOMA News | Press Releases
No recent news for XOMA Corp.
Today’s Trading
| Previous close | 32.51 |
| Today’s open | 33.41 |
| Day’s range | 33.39 - 33.41 |
| Volume | 158 |
| Average volume (3 months) | 47,665 |
| Market cap | $379.8M |
Data as of 3:59pm ET, 07/23/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -255.77% |
| Earnings growth (next 5 years) | +36.00% |
| Revenue growth (last year) | +59.96% |
| P/E ratio | 58.6 |
| Price/Sales | 17.28 |
| Price/Book | 4.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HARPHarpoon Therapeutics... | +0.38 | +3.42% |
| INMBINmune Bio Inc | -1.07 | -4.84% |
| FIXXHomology Medicines I... | -0.10 | -1.52% |
| ---- |
Data as of 3:59pm ET, 07/23/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $29.4M |
| Annual profit (last year) | $8.9M |
| Net profit margin | 30.22% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
